AZD8075 Single Ascending Dose Study

NCT00787072 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

72

Enrollment

INDUSTRY

Sponsor class

Stopped After reports of turbidity in urine in 4 of 8 volunteers in the 4th cohort, the study was halted temporarily.

Conditions

Healthy Volunteers

Interventions

DRUG: AZD8075
DRUG: Placebo

Sponsor

AstraZeneca